<DOC>
	<DOC>NCT01105494</DOC>
	<brief_summary>This multicenter, prospective, observational study will evaluate the quality of life and the factors that influence the quality of life of epoetin beta [Neorecormon] in patients with renal chronic anemia, who are on dialysis. For each eligible patient data will be collected for 6 months. Target sample size is 5000-7000 patients.</brief_summary>
	<brief_title>An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Adult patients &gt;/=18 years of age Dialysis patients with chronic renal anemia Written informed consent Red blood cell transfusion in the previous 2 months Severe neuropsychological disorder Diabetic patients with serious complications This trial is being conducted in Morocco.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>